Spruce Biosciences, Inc.
Spruce Biosciences, Inc. (SPRB) Stock Overview
Explore Spruce Biosciences, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
40.9M
P/E Ratio
-1.39
EPS (TTM)
$-50.83
ROE
-2.04%
SPRB Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Spruce Biosciences, Inc. (SPRB) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 57.77, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $92.39.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -1.39 and a market capitalization of 40.9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.